Application Nr Approved Date Route Status External Links
ANDA206831 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Isosulfan Blue Injection 1% Upon Subcutaneous Administration, Delineates The Lymphatic Vessels Draining The Region Of Injection. It Is An Adjunct To Lymphography In: Primary And Secondary Lymphedema Of The Extremities; Chyluria, Chylous Ascites Or Chylothorax; Lymph Node Involvement By Primary Or Secondary Neoplasm; Lymph Node Response To Therapeutic Modalities (1.1). 1.1 Lymphatic Vessel Delineation Isosulfan Blue Injection 1% Upon Subcutaneous Administration, Delineates Lymphatic Vessels Draining The Region Of Injection. It Is An Adjunct To Lymphography In: Primary And Secondary Lymphedema Of The Extremities; Chyluria, Chylous Ascites Or Chylothorax; Lymph Node Involvement By Primary Or Secondary Neoplasm; And Lymph Node Response To Therapeutic Modalities.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Isosulfan Blue

Comments